Cargando…
Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes
BACKGROUND: Emerging evidence supports that dihydroceramides (DhCer) and ceramides (Cer) contribute to the pathophysiology of insulin resistance and liver steatosis, and that their circulating concentrations are independently associated with cardiovascular outcomes. Circulating DhCer levels are incr...
Autores principales: | Denimal, Damien, Bergas, Victoria, Pais-de-Barros, Jean-Paul, Simoneau, Isabelle, Demizieux, Laurent, Passilly-Degrace, Patricia, Bouillet, Benjamin, Petit, Jean-Michel, Rouland, Alexia, Bataille, Amandine, Duvillard, Laurence, Vergès, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158384/ https://www.ncbi.nlm.nih.gov/pubmed/37143040 http://dx.doi.org/10.1186/s12933-023-01845-0 |
Ejemplares similares
-
Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes
por: Denimal, Damien, et al.
Publicado: (2023) -
HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control
por: Denimal, Damien, et al.
Publicado: (2022) -
Normal HDL Cholesterol Efflux and Anti-Inflammatory Capacities in Type 2 Diabetes Despite Lipidomic Abnormalities
por: Denimal, Damien, et al.
Publicado: (2022) -
Increased body fat mass reduces the association between fructosamine and glycated hemoglobin in obese type 2 diabetes patients
por: Vergès, Bruno, et al.
Publicado: (2020) -
Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion
por: Rouland, Alexia, et al.
Publicado: (2021)